{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T09:53:30Z","timestamp":1794045210751,"version":"4.8.0"},"reference-count":153,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100023674","name":"Deanship of Scientific Research, King Khalid University","doi-asserted-by":"publisher","award":["RGP2\/413\/46"],"award-info":[{"award-number":["RGP2\/413\/46"]}],"id":[{"id":"10.13039\/501100023674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bioadv.2025.214493","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T16:59:04Z","timestamp":1757350744000},"page":"214493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["PEGylated dendrimers for precision cancer therapy: Advances in tumor targeting, drug delivery, and clinical translation"],"prefix":"10.1016","volume":"179","author":[{"given":"Prashant","family":"Kesharwani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Puri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taha","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humood","family":"Al Shmrany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garima","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khang Wen","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioadv.2025.214493_bb0005","series-title":"Nanotechnology-Based Target. Drug Deliv. Syst. Brain Tumors","first-page":"375","article-title":"Carbon Nanotubes (CNTs)","author":"Meher","year":"2018"},{"key":"10.1016\/j.bioadv.2025.214493_bb0010","doi-asserted-by":"crossref","DOI":"10.1080\/07357907.2024.2361295","article-title":"An overview of cancer biology, pathophysiological development and it\u2019s treatment modalities: current challenges of cancer anti-angiogenic therapy","author":"Al-Ostoot","year":"2024","journal-title":"Cancer Investig."},{"key":"10.1016\/j.bioadv.2025.214493_bb0015","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.drudis.2016.06.029","article-title":"Rnai-combined nano-chemotherapeutics to tackle resistant tumors","volume":"21","author":"Tekade","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioadv.2025.214493_bb0020","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1080\/21691401.2024.2368033","article-title":"A review on dendrimer-based nanoconjugates and their intracellular trafficking in cancer photodynamic therapy","volume":"52","author":"Nemakhavhani","year":"2024","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.bioadv.2025.214493_bb0025","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1080\/00914037.2022.2158334","article-title":"Dendrimer as nanocarrier for drug delivery and drug targeting therapeutics: A fundamental to advanced systematic review","volume":"73","author":"Rastogi","year":"2024","journal-title":"Int. J. Polym. Mater. Polym. Biomater."},{"key":"10.1016\/j.bioadv.2025.214493_bb0030","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jcis.2023.01.139","article-title":"Capsaicin-loaded alginate nanoparticles embedded polycaprolactone-chitosan nanofibers as a controlled drug delivery nanoplatform for anticancer activity","volume":"638","author":"Ahmady","year":"2023","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.bioadv.2025.214493_bb0035","article-title":"Recent advances and prospects in gemcitabine drug delivery systems","volume":"592","author":"Paroha","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214493_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2021.03.011","article-title":"The emerging role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer","author":"Singh","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioadv.2025.214493_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2016.06.029","article-title":"Rnai-combined nano-chemotherapeutics to tackle resistant tumors","volume":"21","author":"Tekade","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioadv.2025.214493_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120428","article-title":"Intranasal delivery of naloxone-loaded solid lipid nanoparticles as a promising simple and non-invasive approach for the management of opioid overdose","volume":"599","author":"Hasan","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214493_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.112044","article-title":"Carbon nanotubes as an emerging nanocarrier for the delivery of doxorubicin for improved chemotherapy","volume":"208","author":"Chadar","year":"2021","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.bioadv.2025.214493_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120835","article-title":"Nanotechnology-based siRNA delivery strategies for treatment of triple negative breast cancer","volume":"605","author":"Chadar","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214493_bb0065","article-title":"Update on therapeutic potential of emerging nanoformulations of phytocompounds in Alzheimer\u2019s and Parkinson\u2019s disease","volume":"79","author":"Kanojia","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bioadv.2025.214493_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.614290","article-title":"Formulation and development of transferrin targeted solid lipid nanoparticles for breast Cancer therapy","volume":"11","author":"Bhagwat","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioadv.2025.214493_bb0075","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcis.2016.08.061","article-title":"Solubility enhancement and targeted delivery of a potent anticancer flavonoid analogue to cancer cells using ligand decorated dendrimer nano-architectures","volume":"484","author":"Luong","year":"2016","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.bioadv.2025.214493_bb0080","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jddst.2017.08.005","article-title":"Fabrication and characterization of nifedipine loaded \u03b2-cyclodextrin nanosponges: an in vitro and in vivo evaluation","volume":"41","author":"Shringirishi","year":"2017","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bioadv.2025.214493_bb0085","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.drudis.2015.05.004","article-title":"Validating the anticancer potential of carbon nanotube-based therapeutics through cell line testing","volume":"20","author":"Kesharwani","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioadv.2025.214493_bb0090","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jcis.2017.01.092","article-title":"Synthesis and characterization of folate decorated albumin bio-conjugate nanoparticles loaded with a synthetic curcumin difluorinated analogue","volume":"496","author":"Gawde","year":"2017","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.bioadv.2025.214493_bb0095","first-page":"1478","article-title":"Evaluation of dendrimer safety and efficacy through cell line studies","volume":"12","author":"Kesharwani","year":"2011"},{"key":"10.1016\/j.bioadv.2025.214493_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2022.111471","article-title":"Exploring dendrimer-based drug delivery systems and their potential applications in cancer immunotherapy","volume":"177","author":"Mukherjee","year":"2022","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.bioadv.2025.214493_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2024.113338","article-title":"Understanding the journey of biopolymeric nanoformulations for oral drug delivery: conventional to advanced treatment approaches","volume":"218","author":"Sharma","year":"2024","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.bioadv.2025.214493_bb0110","first-page":"300","article-title":"Nanomaterials in the Wound Healing Process: New Insights and Advancements","volume":"16","author":"Sangnim","year":"2024","journal-title":"Pharm"},{"key":"10.1016\/j.bioadv.2025.214493_bb0115","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.ceramint.2021.09.216","article-title":"A porous calcium-zirconia scaffolds composed of magnetic nanoparticles for bone cancer treatment: fabrication, characterization and FEM analysis","volume":"48","author":"Jasemi","year":"2022","journal-title":"Ceram. Int."},{"key":"10.1016\/j.bioadv.2025.214493_bb0120","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bmt.2023.09.001","article-title":"Review of the efficacy of nanoparticle-based drug delivery systems for cancer treatment","volume":"5","author":"Elumalai","year":"2024","journal-title":"Biomed. Tech."},{"key":"10.1016\/j.bioadv.2025.214493_bb0125","first-page":"852","article-title":"Carrier Systems for Advanced Drug Delivery: Improving Drug Solubility\/Bioavailability and Administration Routes","volume":"16","author":"Losada-Barreiro","year":"2024","journal-title":"Pharm"},{"key":"10.1016\/j.bioadv.2025.214493_bb0130","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.progpolymsci.2013.07.005","article-title":"Dendrimer as nanocarrier for drug delivery","volume":"39","author":"Kesharwani","year":"2014","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.bioadv.2025.214493_bb0135","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.nano.2010.10.010","article-title":"Cancer targeting potential of some ligand-anchored poly(propylene imine) dendrimers: a comparison","volume":"7","author":"Kesharwani","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bioadv.2025.214493_bb0140","article-title":"Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery","author":"Kesharwani","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioadv.2025.214493_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.mattod.2015.06.003","article-title":"PAMAM dendrimers as promising nanocarriers for RNAi therapeutics","author":"Kesharwani","year":"2015","journal-title":"Mater. Today"},{"key":"10.1016\/j.bioadv.2025.214493_bb0150","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.1016\/j.biomaterials.2014.03.064","article-title":"Generation dependent cancer targeting potential of poly(propyleneimine) dendrimer","volume":"35","author":"Kesharwani","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioadv.2025.214493_bb0155","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.pmatsci.2019.03.003","article-title":"Dendrimer-entrapped gold nanoparticles as promising nanocarriers for anticancer therapeutics and imaging","volume":"103","author":"Kesharwani","year":"2019","journal-title":"Prog. Mater. Sci."},{"key":"10.1016\/j.bioadv.2025.214493_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2025.114622","article-title":"Surface-modified nintedanib-loaded solid lipid nanoparticles for effective targeting of non-small cell lung cancer","volume":"251","author":"Nalawade","year":"2025","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.bioadv.2025.214493_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.inoche.2025.114467","article-title":"Gold nanoparticle-enabled doxorubicin delivery: advancing targeted chemotherapy in cancer therapy","volume":"178","author":"Aggarwal","year":"2025","journal-title":"Inorg. Chem. Commun."},{"key":"10.1016\/j.bioadv.2025.214493_bb0170","article-title":"Biomimetic nanoparticles: A revolutionary approach to breast cancer therapy using cell membrane coatings","volume":"107","author":"Chandra","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bioadv.2025.214493_bb0175","article-title":"Green biogenic silver nanoparticles, therapeutic uses, recent advances, risk assessment, challenges, and future perspectives","volume":"77","author":"Ashique","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bioadv.2025.214493_bb0180","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.drudis.2017.06.009","article-title":"Dendrimer nanohybrid carrier systems: an expanding horizon for targeted drug and gene delivery","volume":"23","author":"Kesharwani","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioadv.2025.214493_bb0185","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1007\/s11095-014-1549-2","article-title":"Generation dependent safety and efficacy of folic acid conjugated dendrimer based anticancer drug formulations","volume":"32","author":"Kesharwani","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bioadv.2025.214493_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.111837","article-title":"PAMAM dendrimer as a talented multifunctional biomimetic nanocarrier for cancer diagnosis and therapy","volume":"204","author":"Surekha","year":"2021","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.bioadv.2025.214493_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2016.02.006","article-title":"Dendrimer technologies for brain tumor","volume":"21","author":"Mishra","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioadv.2025.214493_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2021.110683","article-title":"Poly (propylene imine) dendrimer as an emerging polymeric nanocarrier for anticancer drug and gene delivery","volume":"158","author":"Singh","year":"2021","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.bioadv.2025.214493_bb0205","doi-asserted-by":"crossref","DOI":"10.1007\/s11051-013-1625-2","article-title":"The effect of polyethylene glycol spacer chain length on the tumor-targeting potential of folate-modified PPI dendrimers","volume":"15","author":"Thakur","year":"2013","journal-title":"J. Nanopart. Res."},{"issue":"15","key":"10.1016\/j.bioadv.2025.214493_bb0210","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.2217\/nnm.13.210","article-title":"Formulation development and in vitro-in vivo assessment of the fourth-generation PPI dendrimer as a cancer-targeting vector","volume":"9","author":"Kesharwani","year":"2014","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.bioadv.2025.214493_bb0215","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jcis.2016.07.047","article-title":"Ligand anchored poly(propyleneimine) dendrimers for brain targeting: comparative in vitro and in vivo assessment","volume":"482","author":"Patel","year":"2016","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.bioadv.2025.214493_bb0220","doi-asserted-by":"crossref","first-page":"269","DOI":"10.34172\/bi.2020.34","article-title":"Development of binary dispersions and nanocomposites of irbesartan with enhanced antihypertensive activity","volume":"10","author":"Puri","year":"2019","journal-title":"Bioimpacts"},{"key":"10.1016\/j.bioadv.2025.214493_bb0225","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1988","article-title":"Polymer\u2013drug and polymer\u2013protein conjugated nanocarriers: design, drug delivery, imaging, therapy, and clinical applications","volume":"16","author":"Guo","year":"2024","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.bioadv.2025.214493_bb0230","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jconrel.2021.10.028","article-title":"RGD engineered dendrimer nanotherapeutic as an emerging targeted approach in cancer therapy","volume":"340","author":"Sheikh","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214493_bb0235","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejpb.2015.10.015","article-title":"Lyophilized mucoadhesive-dendrimer enclosed matrix tablet for extended oral delivery of albendazole","volume":"102","author":"Mansuri","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bioadv.2025.214493_bb0240","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1021\/acs.molpharmaceut.5b00827","article-title":"In vivo antitumor activity of folate-conjugated cholic acid-polyethylenimine micelles for the codelivery of doxorubicin and siRNA to colorectal adenocarcinomas","volume":"12","author":"Amjad","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bioadv.2025.214493_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122899","article-title":"Nanoparticles in cancer theragnostic and drug delivery: A comprehensive review","volume":"352","author":"Al-Thani","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.bioadv.2025.214493_bb0250","article-title":"Advances in dendritic systems and dendronized nanoparticles: paradigm shifts in cancer targeted therapy and diagnostics","author":"Kedar","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bioadv.2025.214493_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2025.102830","article-title":"Formulation and development of ACUPA-targeting PEGylated nanoliposomes for treatment of prostate cancer","volume":"95","author":"Moosavian","year":"2025","journal-title":"Tissue Cell"},{"key":"10.1016\/j.bioadv.2025.214493_bb0260","doi-asserted-by":"crossref","DOI":"10.1002\/pat.6348","article-title":"Advanced polymeric dendrimers in the management of Alzheimer\u2019s disease","volume":"35","author":"Kapare","year":"2024","journal-title":"Polym. Adv. Technol."},{"key":"10.1016\/j.bioadv.2025.214493_bb0265","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.2147\/IJN.S471734","article-title":"Research progress of disulfide bond based tumor microenvironment targeted drug delivery system","volume":"19","author":"Ma","year":"2024","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bioadv.2025.214493_bb0270","first-page":"1","article-title":"Nanodelivery in gene therapy","author":"Eksi","year":"2024","journal-title":"Handb. Cancer Immunol."},{"key":"10.1016\/j.bioadv.2025.214493_bb0275","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.xphs.2022.11.005","article-title":"The global characterisation of a drug-dendrimer conjugate - PEGylated poly-lysine dendrimer","volume":"112","author":"Akhtar","year":"2023","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bioadv.2025.214493_bb0280","article-title":"Polyethylene glycol-mediated functionalization of nanodelivery systems for improving their pharmacokinetic profile and anticancer efficacy","author":"Al-Shadidi","year":"2024","journal-title":"Int. J. Polym. Mater. Polym. Biomater."},{"key":"10.1016\/j.bioadv.2025.214493_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.progpolymsci.2024.101855","article-title":"Recent developments in synthetic approaches for macromolecular prodrugs","volume":"155","author":"Alex","year":"2024","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.bioadv.2025.214493_bb0290","article-title":"Polyethylene glycol-mediated functionalization of nanodelivery systems for improving their pharmacokinetic profile and anticancer efficacy","author":"Al-Shadidi","year":"2024","journal-title":"Int. J. Polym. Mater. Polym. Biomater."},{"key":"10.1016\/j.bioadv.2025.214493_bb0295","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/08853282231185352","article-title":"The immune-stealth polymeric coating on drug delivery nanocarriers: in vitro engineering and in vivo fate","volume":"38","author":"Shafaei","year":"2023","journal-title":"J. Biomater. Appl."},{"key":"10.1016\/j.bioadv.2025.214493_bb0300","first-page":"445","article-title":"Enhancing drug penetration in solid tumors via nanomedicine: evaluation models, strategies and perspectives","volume":"32","author":"Shen","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bioadv.2025.214493_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112530","article-title":"Aptamer grafted nanoparticle as targeted therapeutic tool for the treatment of breast cancer","volume":"146","author":"Sheikh","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioadv.2025.214493_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2014.12.015","article-title":"Dendrimer generational nomenclature: the need to harmonize","author":"Kesharwani","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioadv.2025.214493_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2021.110746","article-title":"An insight into aptamer engineered dendrimer for cancer therapy","volume":"159","author":"Sheikh","year":"2021","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.bioadv.2025.214493_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2022.111759","article-title":"Galactose engineered nanocarriers: hopes and hypes in cancer therapy","volume":"183","author":"Fatima","year":"2023","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.bioadv.2025.214493_bb0325","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejpb.2021.02.010","article-title":"Recent update of toxicity aspects of nanoparticulate systems for drug delivery","volume":"161","author":"Patnaik","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bioadv.2025.214493_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2019.e01343","article-title":"Dendrimer entrapped microsponge gel of dithranol for effective topical treatment","volume":"5","author":"Tripathi","year":"2019","journal-title":"Heliyon"},{"key":"10.1016\/j.bioadv.2025.214493_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2017.04.010","article-title":"Lipid based nanocarriers system for topical delivery of photosensitizers","volume":"22","author":"Md","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioadv.2025.214493_bb0340","doi-asserted-by":"crossref","first-page":"10082","DOI":"10.3390\/ijms241210082","article-title":"Perspectives for improving the tumor targeting of nanomedicine via the EPR effect in clinical tumors","volume":"24","author":"Kim","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioadv.2025.214493_bb0345","doi-asserted-by":"crossref","DOI":"10.1080\/17425247.2024.2394631","article-title":"Dendrimer-mediated targeting of angiogenic biomarkers: therapeutic intervention against cancer","author":"Pathak","year":"2024","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.bioadv.2025.214493_bb0350","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3390\/cancers16020461","article-title":"Targeted Therapeutic Strategies for the Treatment of Cancer","volume":"16","author":"Victoir","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.bioadv.2025.214493_bb0355","article-title":"Efficient PEGylated dendrimer nanoplatform for codelivery of hyaluronidase and methotrexate: a new frontier in chemotherapeutic efficacy and tumor penetration","author":"Soozanipour","year":"2024","journal-title":"ACS Appl. Nano Mater."},{"key":"10.1016\/j.bioadv.2025.214493_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.actbio.2016.07.015","article-title":"PEGylated PAMAM dendrimers: enhancing efficacy and mitigating toxicity for effective anticancer drug and gene delivery","author":"Luong","year":"2016","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bioadv.2025.214493_bb0365","first-page":"77","article-title":"Synthesize and characterization of a novel cadmium selenide nanoparticle with Iron precursor applicable in hyperthermia of Cancer cells","volume":"17","author":"Akbari-Aghdam","year":"2021","journal-title":"Int. J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.bioadv.2025.214493_bb0370","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.1039\/D4TB00737A","article-title":"Advances in drug delivery-based therapeutic strategies for renal fibrosis treatment","volume":"12","author":"Huang","year":"2024","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.bioadv.2025.214493_bb0375","article-title":"Advancements in dendrimer-based drug delivery for combinatorial cancer therapy","volume":"97","author":"Arif","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bioadv.2025.214493_bb0380","first-page":"1","article-title":"A comprehensive review on doxorubicin: mechanisms, toxicity, clinical trials, combination therapies and nanoformulations in breast cancer","volume":"2024","author":"Bisht","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.bioadv.2025.214493_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2022.111635","article-title":"Dendrimers as prospective nanocarrier for targeted delivery against lung cancer","volume":"180","author":"Arora","year":"2022","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.bioadv.2025.214493_bb0390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22062912","article-title":"Recent advances in preclinical research using PAMAM dendrimers for cancer gene therapy","volume":"22","author":"Tarach","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioadv.2025.214493_bb0395","article-title":"Micro-Nanocarriers based drug delivery Technology for Blood-Brain Barrier Crossing and Brain Tumor Targeting Therapy","volume":"18","author":"Wang","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.bioadv.2025.214493_bb0400","doi-asserted-by":"crossref","first-page":"8304","DOI":"10.3390\/ijms25158304","article-title":"Targeted Nanocarrier-Based Drug Delivery Strategies for Improving the Therapeutic Efficacy of PARP Inhibitors against Ovarian Cancer","volume":"25","author":"Gralewska","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioadv.2025.214493_bb0405","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.3390\/pharmaceutics15092233","article-title":"Recent advances in targeted drug delivery strategy for enhancing oncotherapy","volume":"15","author":"Li","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioadv.2025.214493_bb0410","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1159131","article-title":"Dendrimer: an update on recent developments and future opportunities for the brain tumors diagnosis and treatment","volume":"14","author":"Kaurav","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioadv.2025.214493_bb0415","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/17460441.2023.2211801","article-title":"Promising strategies for improving oral bioavailability of poor water-soluble drugs","volume":"18","author":"Rocha","year":"2023","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.bioadv.2025.214493_bb0420","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.polymer.2014.12.051","article-title":"Impact of pegylation on biopharmaceutical properties of dendrimers","volume":"59","author":"Thakur","year":"2015","journal-title":"Polymer (Guildf)."},{"key":"10.1016\/j.bioadv.2025.214493_bb0425","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jconrel.2021.07.036","article-title":"Clinical diagonal translation of nanoparticles: case studies in dendrimer nanomedicine","volume":"337","author":"Mignani","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214493_bb0430","first-page":"24","article-title":"Current update on nanoplatforms as therapeutic and diagnostic tools: a review for the materials used as nanotheranostics and imaging modalities","volume":"16","author":"Siafaka","year":"2021","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.bioadv.2025.214493_bb0435","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.3390\/pharmaceutics15051406","article-title":"Dendrimers: advancements and potential applications in cancer diagnosis and treatment\u2014an overview","volume":"15","author":"Crintea","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioadv.2025.214493_bb0440","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1752","article-title":"Dendrimers for cancer immunotherapy: avidity-based drug delivery vehicles for effective anti-tumor immune response","volume":"14","author":"Rawding","year":"2022","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.bioadv.2025.214493_bb0445","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jconrel.2017.09.026","article-title":"Preclinical development of drug delivery systems for paclitaxel-based cancer chemotherapy","volume":"267","author":"Wang","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214493_bb0450","first-page":"396","article-title":"Engineered smart materials for RNA based molecular therapy to treat glioblastoma","volume":"33","author":"Singh","year":"2024","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bioadv.2025.214493_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2022.100097","article-title":"Nanoparticle-assisted targeting of the tumour microenvironment","volume":"8","author":"Sim","year":"2022","journal-title":"OpenNano"},{"key":"10.1016\/j.bioadv.2025.214493_bb0460","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jconrel.2009.01.002","article-title":"Sustained and efficient porphyrin generation in vivo using dendrimer conjugates of 5-ALA for photodynamic therapy","volume":"135","author":"Casas","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214493_bb0465","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s10238-023-01262-3","article-title":"Recent nanotheranostic approaches in cancer research","volume":"24","author":"Gupta","year":"2024","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.bioadv.2025.214493_bb0470","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19103264","article-title":"Nanoparticle-mediated combination therapy: two-in-one approach for cancer","volume":"19","author":"Gurunathan","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioadv.2025.214493_bb0475","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jconrel.2016.06.012","article-title":"Nanomedicine of synergistic drug combinations for cancer therapy \u2013 strategies and perspectives","volume":"240","author":"Zhang","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214493_bb0480","doi-asserted-by":"crossref","first-page":"21365","DOI":"10.1039\/D3RA02969G","article-title":"Nanoparticle-based drug delivery systems targeting cancer cell surfaces","volume":"13","author":"Hong","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioadv.2025.214493_bb0485","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3109\/09687688.2010.521200","article-title":"Receptor-targeted nanocarriers for therapeutic delivery to cancer","volume":"27","author":"Yu","year":"2010","journal-title":"Mol. Membr. Biol."},{"key":"10.1016\/j.bioadv.2025.214493_bb0490","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ijpharm.2017.01.044","article-title":"Smart AS1411-aptamer conjugated pegylated PAMAM dendrimer for the superior delivery of camptothecin to colon adenocarcinoma in vitro and in vivo","volume":"519","author":"Alibolandi","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214493_bb0495","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1021\/mp9001206","article-title":"Synthesis and in vivo antitumor efficacy of PEGylated poly(l-lysine) dendrimer-camptothecin conjugates","volume":"6","author":"Fox","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bioadv.2025.214493_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2022.111547","article-title":"PEGylated G4 dendrimers as a promising nanocarrier for piperlongumine delivery: synthesis, characterization, and anticancer activity","volume":"179","author":"Jangid","year":"2022","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.bioadv.2025.214493_bb0505","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1080\/03639045.2019.1680995","article-title":"Co-delivery of doxorubicin and TRAIL plasmid by modified PAMAM dendrimer in colon cancer cells, in vitro and in vivo evaluation","volume":"45","author":"Pishavar","year":"2019","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.bioadv.2025.214493_bb0510","doi-asserted-by":"crossref","first-page":"6576","DOI":"10.1016\/j.biomaterials.2014.04.043","article-title":"PEGylated PAMAM dendrimer-doxorubicin conjugate-hybridized gold nanorod for combined photothermal-chemotherapy","volume":"35","author":"Li","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioadv.2025.214493_bb0515","doi-asserted-by":"crossref","DOI":"10.1002\/app.40358","article-title":"Antitumor efficacy of doxorubicin encapsulated within PEGylated poly(amidoamine) dendrimers","volume":"131","author":"Liao","year":"2014","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.bioadv.2025.214493_bb0520","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.colsurfb.2019.01.014","article-title":"Synthesis and characterization of magnetized-PEGylated dendrimer anchored to thermosensitive polymer for letrozole drug delivery","volume":"176","author":"Hooshyar","year":"2019","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.bioadv.2025.214493_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119389","article-title":"PEGylated dendrimer mediated delivery of Bortezomib: drug conjugation versus encapsulation","volume":"584","author":"Sahoo","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214493_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2021.110491","article-title":"Pegylated bis-indolyl polyurethane dendrimer: empty drug carrier with prominent anticancer activity","volume":"153","author":"Bargathulla","year":"2021","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.bioadv.2025.214493_bb0535","doi-asserted-by":"crossref","first-page":"6865","DOI":"10.1021\/acsami.6b15505","article-title":"Enzyme-sensitive and amphiphilic PEGylated dendrimer-paclitaxel prodrug-based nanoparticles for enhanced stability and anticancer efficacy","volume":"9","author":"Li","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bioadv.2025.214493_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124193","article-title":"Attenuated polyethylene glycol immunogenicity and overcoming accelerated blood clearance of a fully PEGylated dendrimer","volume":"659","author":"Kojima","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214493_bb0545","doi-asserted-by":"crossref","DOI":"10.1088\/2043-6262\/4\/4\/045013","article-title":"Dendrimer-based nanocarriers demonstrating a high efficiency for loading and releasing anticancer drugs against cancer cells in vitro and in vivo","volume":"4","author":"Tran","year":"2013","journal-title":"Adv. Nat. Sci. Nanosci. Nanotechnol."},{"key":"10.1016\/j.bioadv.2025.214493_bb0550","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1166\/jbn.2013.1479","article-title":"Dendrimer and its effect in fluorouracil loading and release fPegylatedor enhancing antitumor activity","volume":"9","author":"Ly","year":"2013","journal-title":"J. Biomed. Nanotechnol."},{"issue":"21","key":"10.1016\/j.bioadv.2025.214493_bb0555","first-page":"1","article-title":"PEGylated poly(amidoamine) dendrimers-based drug loading vehicles for delivering carboplatin in treatment of various cancerous cells","volume":"212","author":"Ho","year":"2019","journal-title":"J. Nanopart. Res."},{"key":"10.1016\/j.bioadv.2025.214493_bb0560","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2014.03.012","article-title":"Pulmonary administration of a doxorubicin-conjugated dendrimer enhances drug exposure to lung metastases and improves cancer therapy","volume":"183","author":"Kaminskas","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214493_bb0565","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijpharm.2018.12.069","article-title":"Biotin functionalized PEGylated poly(amidoamine) dendrimer conjugate for active targeting of paclitaxel in cancer","volume":"557","author":"Rompicharla","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214493_bb0570","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.biomaterials.2010.09.002","article-title":"PEGylated poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors","volume":"32","author":"He","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioadv.2025.214493_bb0575","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.colsurfb.2016.08.002","article-title":"PEGylated Polyamidoamine dendrimer conjugated with tumor homing peptide as a potential targeted delivery system for glioma","volume":"147","author":"Jiang","year":"2016","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.bioadv.2025.214493_bb0580","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.biomaterials.2009.10.044","article-title":"Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: the effects of PEGylation degree and drug conjugation style","volume":"31","author":"Zhu","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioadv.2025.214493_bb0585","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0378-5173(03)00132-7","article-title":"A PEGylated dendritic nanoparticulate carrier of fluorouracil","volume":"257","author":"Bhadra","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214493_bb0590","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10030162","article-title":"Doxorubicin-conjugated PAMAM dendrimers for ph-responsive drug release and folic acid-targeted cancer therapy","volume":"10","author":"Zhang","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioadv.2025.214493_bb0595","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jconrel.2006.09.012","article-title":"PEGylated lysine dendrimers for tumor-selective targeting after intravenous injection in tumor-bearing mice","volume":"116","author":"Okuda","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214493_bb0600","doi-asserted-by":"crossref","DOI":"10.1166\/jbn.2015.1865","article-title":"PEGylated dendrimer-doxorubicin cojugates as pH-sensitive drug delivery systems: synthesis and in vitro characterization","author":"She","year":"2015","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.bioadv.2025.214493_bb0605","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1021\/bc800125u","article-title":"Folate and folate-PEG-PAMAM dendrimers: synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice","volume":"19","author":"Singh","year":"2008","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.bioadv.2025.214493_bb0610","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10965-019-1779-4","article-title":"Preparation and characterization of oxaliplatin drug delivery vehicle based on PEGylated half-generation PAMAM dendrimer","volume":"26","author":"Nguyen","year":"2019","journal-title":"J. Polym. Res."},{"key":"10.1016\/j.bioadv.2025.214493_bb0615","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-27400-6","article-title":"PEGylation of polypropylenimine dendrimers: effects on cytotoxicity, DNA condensation, gene delivery and expression in cancer cells","author":"Somani","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioadv.2025.214493_bb0620","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.nano.2015.11.012","article-title":"Targeted nanosystems: advances in targeted dendrimers for cancer therapy","volume":"12","author":"Yang","year":"2016","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.bioadv.2025.214493_bb0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124573","article-title":"Dendrimers as drug delivery systems for oncotherapy: current status of promising applications","volume":"663","author":"Sueyoshi","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214493_bb0630","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1021\/acs.chas.3c00104","article-title":"Advancing era and rising concerns in nanotechnology-based cancer treatment","volume":"31","author":"Tiwari","year":"2024","journal-title":"ACS Chem. Health Saf."},{"key":"10.1016\/j.bioadv.2025.214493_bb0635","doi-asserted-by":"crossref","DOI":"10.1021\/acsabm.4c01797","article-title":"Exploring the potential of nanocarriers for cancer immunotherapy: insights into mechanism, nanocarriers, and regulatory perspectives","author":"Kanp","year":"2025","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.bioadv.2025.214493_bb0640","doi-asserted-by":"crossref","first-page":"170","DOI":"10.2174\/0126673878301004240703073107","article-title":"Functionalised ligand-based nanomaterial drug targeting approaches for colorectal cancer therapy","volume":"18","author":"Dixit","year":"2024","journal-title":"Recent Adv. Drug Deliv. Formul."},{"issue":"27","key":"10.1016\/j.bioadv.2025.214493_bb0645","first-page":"1","article-title":"Advanced cancer targeting using aptamer functionalized nanocarriers for site-specific cargo delivery","volume":"271","author":"Narwade","year":"2023","journal-title":"Biomater. Res."},{"key":"10.1016\/j.bioadv.2025.214493_bb0650","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1021\/acsami.9b19830","article-title":"Materials for interfaces in organic solar cells and photodetectors","volume":"12","author":"Li","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bioadv.2025.214493_bb0655","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1021\/ja00968a057","article-title":"Plant antitumor agents. I. The isolation and structure of Camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata","volume":"88","author":"Wall","year":"1966","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioadv.2025.214493_bb0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216461","article-title":"Precise delivery of celastrol by PEGylated aptamer dendrimer nanoconjugates for enormous therapeutic effect via superior intratumor penetration over antibody counterparts","volume":"579","author":"Niu","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bioadv.2025.214493_bb0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.prmcm.2024.100447","article-title":"Unlocking therapeutic precision: \u201cCamptotheca acuminata, a traditional chinese herb tailored for phytonano-cancer theranostics,\u201d","volume":"11","author":"Adak","year":"2024","journal-title":"Pharmacol. Res. - Mod. Chinese Med."},{"key":"10.1016\/j.bioadv.2025.214493_bb0670","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1021\/acs.jmedchem.3c02115","article-title":"Unleashing the potential of Camptothecin: exploring innovative strategies for structural modification and therapeutic advancements","volume":"67","author":"Chen","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioadv.2025.214493_bb0675","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejmech.2018.06.057","article-title":"Piperlongumine (piplartine) as a lead compound for anticancer agents - synthesis and properties of analogues: A mini-review","volume":"156","author":"Piska","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioadv.2025.214493_bb0680","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104772","article-title":"Piperlongumine, a potent anticancer phytotherapeutic: perspectives on contemporary status and future possibilities as an anticancer agent","volume":"156","author":"Tripathi","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bioadv.2025.214493_bb0685","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1208\/s12249-017-0913-z","article-title":"Evaluation of efficiency of modified Polypropylenimine (PPI) with alkyl chains as non-viral vectors used in co-delivery of doxorubicin and TRAIL plasmid","volume":"19","author":"Ebrahimian","year":"2018","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.bioadv.2025.214493_bb0690","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jconrel.2013.04.010","article-title":"Recent advances in delivery of drug-nucleic acid combinations for cancer treatment","volume":"172","author":"Li","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214493_bb0695","first-page":"1","article-title":"Polymeric nanostructures revolutionizing cervical cancer: diagnostics, therapeutics, and theranostics","volume":"2024","author":"Dey","year":"2024","journal-title":"BioNanoScience"},{"key":"10.1016\/j.bioadv.2025.214493_bb0700","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2020.109546","article-title":"Recent advances in dendrimer-based nanoplatform for cancer treatment: A review","volume":"126","author":"Ambekar","year":"2020","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.bioadv.2025.214493_bb0705","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11095-009-9992-1","article-title":"PEGylated PAMAM dendrimer-doxorubicin conjugates: in vitro evaluation and in vivo tumor accumulation","volume":"27","author":"Zhu","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bioadv.2025.214493_bb0710","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.3390\/polym15092028","article-title":"Chitosan-Based Polymer Blends for Drug Delivery Systems","volume":"15","author":"Kaur","year":"2023","journal-title":"Polym"},{"key":"10.1016\/j.bioadv.2025.214493_bb0715","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.ijbiomac.2017.01.147","article-title":"Fabrication of letrozole formulation using chitosan nanoparticles through ionic gelation method","volume":"104","author":"Gomathi","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioadv.2025.214493_bb0720","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.talanta.2013.09.015","article-title":"Synthesis and characterization of poly[1-(N,N-bis-carboxymethyl)amino-3-allylglycerol-co-dimethylacrylamide] grafted to magnetic nano-particles for extraction and determination of letrozole in biological and pharmaceutical samples","volume":"117","author":"Panahi","year":"2013","journal-title":"Talanta"},{"key":"10.1016\/j.bioadv.2025.214493_bb0725","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1166\/jbn.2014.1743","article-title":"Enhancing proteasome-lnhibitor effect by functionalized gold nanoparticles","volume":"10","author":"Coelho","year":"2014","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.bioadv.2025.214493_bb0730","doi-asserted-by":"crossref","first-page":"700","DOI":"10.3892\/ijmm.2020.4637","article-title":"Rotenone restrains colon cancer cell viability, motility and epithelial-mesenchymal transition and tumorigenesis in nude mice via the PI3K\/AKT pathway","volume":"46","author":"Xiao","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bioadv.2025.214493_bb0735","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2014.06.046","article-title":"PEG \u2014 A versatile conjugating ligand for drugs and drug delivery systems","volume":"192","author":"Kolate","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214493_bb0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2013.07.026","article-title":"The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage","author":"Abu Lila","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214493_bb0745","article-title":"Nanocarrier centered therapeutic approaches: recent developments with insight towards the future in the management of lung cancer","volume":"60","author":"Vanza","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bioadv.2025.214493_bb0750","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2147\/IJN.S29997","article-title":"Inhaled chemotherapy in lung cancer: future concept of nanomedicine","volume":"7","author":"Zarogoulidis","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bioadv.2025.214493_bb0755","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0076-6879(05)91004-5","article-title":"The liposomal formulation of doxorubicin","volume":"391","author":"Abraham","year":"2005","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bioadv.2025.214493_bb0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2019.110770","article-title":"PEGylated nanocarriers: a promising tool for targeted delivery to the brain","volume":"187","author":"Gajbhiye","year":"2020","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.bioadv.2025.214493_bb0765","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3390\/molecules29051076","article-title":"Adjuvant novel nanocarrier-based targeted therapy for lung cancer","volume":"29","author":"Sarma","year":"2024","journal-title":"Molecules"}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950825003206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950825003206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T05:55:20Z","timestamp":1760075720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772950825003206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":153,"alternative-id":["S2772950825003206"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2025.214493","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PEGylated dendrimers for precision cancer therapy: Advances in tumor targeting, drug delivery, and clinical translation","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2025.214493","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"214493"}}